Free Trial

AMGEN Mega-Deal Expected

PIPELINE
  • Date $MM Issuer (Priced *, Launch #)
  • 02/15 $Benchmark Amgen expected to issue multi-tranche "mega" debt deal today, estimates as high as $25B to help finance it's $28B acquisition of Horizon Pharmaceuticals in 2022.
  • 02/15 $Benchmark MUFG 3NC2 +130a, mNC2 SOFR, 6NC5 +170a, 8NC7 +185a, 11NC10 +195a
  • 02/15 $Benchmark Gov of Sharjah +9Y +310a
  • 02/16 $Benchmark - Adani Group, beleaguered Indian corp to hold investor calls 2/16 and 2/21

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.